Acerta Pharma B.V. et al v. Pharmacyclics LLC et al
Plaintiff: AstraZeneca Pharmaceuticals LP, Acerta Pharma B.V. and AstraZeneca UK Ltd.
Defendant: AbbVie Inc. and Pharmacyclics LLC
Intervenor Defendant: Janssen Biotech, Inc.
Case Number: 1:2018cv00581
Filed: April 18, 2018
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: New Castle
Presiding Judge: Vacant Judgeship (2017)
Referring Judge: Richard G Andrews
2 Judge: Mary Pat Thynge
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Plaintiff
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on April 2, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 2, 2019 Filing 75 NOTICE of Subpoenas by AbbVie Inc., Pharmacyclics LLC (Attachments: #1 Exhibit A-B)(Tigan, Jeremy)
April 2, 2019 Filing 74 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production (Nos. (1-129) filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam)
March 22, 2019 Pro Hac Vice Attorney Robert Smyth for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00581-RGA, 1:17-cv-01582-RGA(ceg)
March 19, 2019 Filing 73 MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD. - filed by Acerta Pharma B.V.. (Gorman, John)
March 19, 2019 Opinion or Order SO ORDERED, re #73 MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD., filed by Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 3/19/2019. (nms)
March 18, 2019 Filing 72 MOTION for Pro Hac Vice Appearance of Attorney Isaac J. Weingram - filed by Janssen Biotech, Inc.. (Tigan, Jeremy)
March 18, 2019 Opinion or Order SO ORDERED, re #72 MOTION for Pro Hac Vice Appearance of Attorney Isaac J. Weingram, filed by Janssen Biotech, Inc.. Signed by Judge Richard G. Andrews on 3/18/2019. (nms)
March 15, 2019 Filing 71 NOTICE OF SERVICE of 1) Defendants' First Set of Requests for Admission to Plaintiffs (Nos. 1-8) and 2) Defendants' First Set of Interrogatories to Plaintiffs (Nos. 1-15) filed by AbbVie Inc., Pharmacyclics LLC.(Tigan, Jeremy)
March 14, 2019 Filing 70 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam)
March 11, 2019 Filing 69 NOTICE OF SERVICE of (1) Defendants' Responses and Objections to Plaintiffs' First Requests for Production of Documents (Nos. 1-79), and (2) Intervenor Janssen Biotech, Inc.'s Objections and Responses to Plaintiffs' First Requests for Production of Documents (Nos. 1-61) filed by AbbVie Inc., Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy)
February 20, 2019 Filing 68 NOTICE OF SERVICE of Intervenor's First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-39) filed by Janssen Biotech, Inc..(Tigan, Jeremy)
February 13, 2019 Filing 67 NOTICE OF SERVICE of Defendants' First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-129) filed by AbbVie Inc., Pharmacyclics LLC.(Tigan, Jeremy)
February 12, 2019 Pro Hac Vice Attorney James Kirkpatrick for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
February 8, 2019 Opinion or Order SO ORDERED, re #66 MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick, filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. Signed by Judge Richard G. Andrews on 2/8/2019. (nms)
February 4, 2019 Filing 66 MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Poff, Adam)
January 29, 2019 Filing 65 NOTICE OF SERVICE of 1) Plaintiffs First Requests for Production of Documents to Defendants Pharmacyclics LLC and AbbVie Inc. (Nos. 1-79) and 2) Plaintiffs First Requests for Production of Documents to Intervenor Janssen Biotech, Inc. (Nos. 1-61) filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam)
January 25, 2019 Pro Hac Vice Attorney Michael A. Morin for AbbVie Inc., Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
January 14, 2019 Opinion or Order SO ORDERED, re #64 STIPULATION TO EXTEND TIME for Rule 26(e) Supplementations to October 11, 2019. Signed by Judge Richard G. Andrews on 1/14/2019. (nms)
January 11, 2019 Filing 64 STIPULATION TO EXTEND TIME for Rule 26(e) Supplementations to October 11, 2019 - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Poff, Adam)
January 10, 2019 Filing 63 NOTICE OF SERVICE of Defendants and Intervenor's Disclosures Pursuant to Paragraph 3 ofthe Default Standard for Discovery, including Discovery of Electronically Stored Information filed by AbbVie Inc., Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy)
January 10, 2019 Filing 62 NOTICE OF SERVICE of 1) Plaintiffs Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and 2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patent filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam)
December 27, 2018 Filing 61 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Kraman, Pilar)
December 26, 2018 Filing 60 NOTICE OF SERVICE of Defendants and Intervenor's Initial Disclosure Pursuant to Fed. R. Civ. P. 26(a)(1) filed by AbbVie Inc., Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy)
December 21, 2018 Filing 59 Official Transcript of Scheduling Conference held on 12/11/18 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/11/2019. Redacted Transcript Deadline set for 1/22/2019. Release of Transcript Restriction set for 3/21/2019. (Triozzi, Heather)
December 21, 2018 Opinion or Order Filing 58 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 4/4/2019. Amended Pleadings due by 4/4/2019. Fact Discovery completed by 10/11/2019. Dispositive Motions due by 8/7/2020. A Joint Claim Construction Brief due by 7/12/2019. A Markman Hearing is set for 8/22/2019, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 12/21/2020, at 8:30 AM in Courtroom 6A. A 5 day Jury Trial is set to start 1/4/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/21/2018. (nms)
December 20, 2018 Filing 57 PROPOSED Scheduling Order, by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Poff, Adam) Modified on 12/21/2018 (nms).
December 18, 2018 Filing 56 ANSWER to #50 Answer to Complaint, Counterclaim by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Kraman, Pilar)
December 11, 2018 Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 12/11/2018. Counsel for Plaintiff to submit a revised Order with agreed upon dates. (Court Reporter Heather Triozzi.) (ksr, )
November 30, 2018 Opinion or Order Filing 55 ORAL ORDER: The Rule 16(b) Scheduling Conference is now reset for 12/11/2018, at 4:00 PM in Chambers before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 11/30/2018. (nms)
November 29, 2018 Opinion or Order Filing 54 ORAL ORDER: Due to a scheduling conflict the conference set for 11/30/2018, is CANCELLED, and will be reset for a date to be determined. Ordered by Judge Richard G. Andrews on 11/29/2018. (nms)
November 28, 2018 Filing 53 PROPOSED Scheduling Order, by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Attachments: #1 Exhibits A-B)(Poff, Adam) Modified on 11/29/2018 (nms).
November 28, 2018 Filing 52 MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman and Lachlan Campbell-Verduyn - filed by Janssen Biotech, Inc.. (Tigan, Jeremy)
November 28, 2018 Opinion or Order SO ORDERED, re #52 MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman and Lachlan Campbell-Verduyn, filed by Janssen Biotech, Inc.. Signed by Judge Richard G. Andrews on 11/28/2018. (nms)
November 27, 2018 Filing 51 REDACTED VERSION of #47 Opening Brief in Support, by Janssen Biotech, Inc.. (Tigan, Jeremy) Modified on 11/27/2018 (nms).
November 27, 2018 Filing 50 ANSWER to #1 Complaint with Jury Demand, and COUNTERCLAIMS against Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd., by Janssen Biotech, Inc..(Tigan, Jeremy) Modified on 11/28/2018 (nms).
November 26, 2018 Opinion or Order Filing 49 ORDER: The Motion Intervene (D.I. #46 ) is GRANTED. Signed by Judge Richard G. Andrews on 11/26/2018. (nms)
November 23, 2018 Filing 48 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc.. (Blumenfeld, Jack)
November 21, 2018 Filing 47 [SEALED] OPENING BRIEF in Support re #46 MOTION to Intervene filed by Janssen Biotech, Inc..Answering Brief/Response due date per Local Rules is 12/5/2018. (Attachments: #1 Exhibits 1-3)(Tigan, Jeremy)
November 21, 2018 Filing 46 MOTION to Intervene - filed by Janssen Biotech, Inc.. (Attachments: #1 Exhibit A)(Tigan, Jeremy)
November 20, 2018 Opinion or Order Filing 45 ORDER Setting Mediation Conference: A Telephone Conference is set for 3/4/2019 at 10:45 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 11/20/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb)
November 8, 2018 Pro Hac Vice Attorney Eric Kraeutler for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
November 8, 2018 Pro Hac Vice Attorney Olga Berson for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
November 8, 2018 Pro Hac Vice Attorney John V. Gorman for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
November 7, 2018 Filing 44 MOTION for Pro Hac Vice Appearance of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D. - filed by Acerta Pharma B.V.. (Attachments: #1 Certification, #2 Certification, #3 Certification)(Barillare, Jody) Modified on 11/7/2018 (nms).
November 7, 2018 Opinion or Order SO ORDERED, re #44 MOTION for Pro Hac Vice Appearance of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D., filed by Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 11/7/2018. (nms)
November 7, 2018 CORRECTING ENTRY: The pdfs for D.I. #38 and D.I. #39 have been replaced per counsel's request. The captions on the filings have been corrected. (nms)
November 6, 2018 Filing 43 ANSWER to #39 Answer to Complaint and Counterclaims, by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam) Modified on 11/7/2018 (nms).
November 6, 2018 Filing 42 ANSWER to #38 Answer to Complaint, and Counterclaims, by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam) Modified on 11/7/2018 (nms).
October 23, 2018 Opinion or Order Filing 41 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 11/30/2018, at 2:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 10/23/2018. (nms)
October 23, 2018 Opinion or Order Filing 40 ORDER Setting Mediation Conference: A Telephone Conference is set for 11/19/2018 at 10:15 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 10/23/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb)
October 22, 2018 CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(cak)
October 16, 2018 Filing 39 ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against All Plaintiffs by AbbVie Inc..(Tigan, Jeremy) (Main Document 39 replaced on 11/7/2018) (nms).
October 16, 2018 Filing 38 ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. by Pharmacyclics LLC.(Tigan, Jeremy) (Main Document 38 replaced on 11/7/2018) (nms).
October 3, 2018 Opinion or Order Filing 37 ORDER: The motions to consolidate (D.I. 49 in C.A. 17-1582-RGA; D.I. 12 in C.A. 18-581-RGA) and the motion for leave to amend answer, etc. (D.I. 56 in C.A. 17-1582-RGA) are DENIED. Further, the scheduling order (D.I. 29 in C.A. 17-1582-RGA) is MODIFIED to reflect a jury trial will be five days long. Signed by Judge Richard G. Andrews on 10/3/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(nms)
October 2, 2018 Opinion or Order Filing 36 ORAL ORDER: The motion to dismiss (D.I. #17 ) is DENIED. It is premature and cannot be decided on the present record. Ordered by Judge Richard G. Andrews on 10/2/2018. (nms)
September 6, 2018 Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA (rjb)
August 16, 2018 Filing 35 REQUEST for Oral Argument by AbbVie Inc., Pharmacyclics LLC re #17 MOTION to Dismiss for Failure to State a Claim . (Tigan, Jeremy)
August 13, 2018 Filing 34 DECLARATION of G. Sobolski re #33 Reply Brief, by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms).
August 13, 2018 Filing 33 REPLY BRIEF re #17 MOTION to Dismiss for Failure to State a Claim filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
August 3, 2018 Opinion or Order Filing 32 ORDER approving #31 STIPULATION TO EXTEND TIME Defendants to file a reply brief in support of their Motion to Dismiss to August 13, 2018. ORDER re-setting briefing schedule re #17 MOTION to Dismiss for Failure to State a Claim : (Reply Brief due 8/13/2018.) Signed by Judge Eduardo C. Robreno on 8/3/2018. (nmf)
August 2, 2018 Filing 31 STIPULATION TO EXTEND TIME Defendants to file a reply brief in support of their Motion to Dismiss to August 13, 2018 - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
July 30, 2018 Filing 30 ANSWERING BRIEF in Opposition re #17 MOTION to Dismiss for Failure to State a Claim filed by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..Reply Brief due date per Local Rules is 8/6/2018. (Attachments: #1 Exhibit A, #2 Certificate of Service)(Kraman, Pilar)
July 27, 2018 Filing 29 REPLY BRIEF re #12 MOTION to Consolidate Cases filed by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Attachments: #1 Exhibit A through C, #2 Certificate of Service)(Kraman, Pilar)
July 18, 2018 Opinion or Order Filing 28 ORDER approving #27 STIPULATION TO EXTEND TIME 1) in C.A. 17-1582-ER for Plaintiff Pharmacyclics to respond to Defendants Motion to Amend [D.I. 56]; and (2) the deadlines in both C.A. 17-1582-ER and C.A. 18-581-ER for AstraZeneca and Acerta to file a reply brief in support, ORDER re-setting briefing schedule re #12 MOTION to Consolidate Cases : (Reply Brief due 7/27/2018.) Signed by Judge Eduardo C. Robreno on 7/18/2018. (nmf)
July 18, 2018 Filing 27 STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 9/6/2018 (nms).
July 13, 2018 Filing 26 ANSWERING BRIEF in Opposition re #12 MOTION to Consolidate Cases filed by AbbVie Inc., Pharmacyclics LLC.Reply Brief due date per Local Rules is 7/20/2018. (Attachments: #1 Exhibits A-B)(Tigan, Jeremy)
July 10, 2018 Opinion or Order Filing 25 ORDER granting #23 MOTION for Pro Hac Vice Appearance of Attorney David P. Frazier. Signed by Judge Eduardo C. Robreno on 7/10/2018. (crb)
July 10, 2018 Opinion or Order Filing 24 ORDER approving #21 STIPULATION TO EXTEND TIME. Reset Briefing Schedule: Deadline for plaintiffs to respond to Motion to Dismiss #17 and Defendants' time to respond to Plaintiff's Motion to Consolidate #12 to July 30, 2018 and July 13, 2018, respectively. Signed by Judge Eduardo C. Robreno on 7/10/2018. (crb)
July 10, 2018 Filing 23 MOTION for Pro Hac Vice Appearance of Attorney David P. Frazier - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
July 10, 2018 Opinion or Order Filing 22 ORDER granting #20 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, Gregory K. Sobolski, Brenda L. Danek, Lauren K. Sharkey, and Lesley M. Hamming. Signed by Judge Eduardo C. Robreno on 7/9/2018. (crb)
July 10, 2018 Reset Briefing Schedule: Deadline for defendants to respond to #12 MOTION to Consolidate Cases extended. Answering Brief due 7/13/2018. Signed by Judge Eduardo C. Robreno on 7/10/2018. (crb)
July 9, 2018 Case Reassigned to Judge Eduardo C. Robreno of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (ER) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-ER, 1:18-cv-00581-ER (rjb)
July 2, 2018 Filing 21 STIPULATION TO EXTEND TIME Plaintiffs' time to respond to Defendants' Motion to Dismiss and Defendants' time to respond to Plaintiffs' Motion to Consolidate to July 30, 2018 and July 13, 2018, respectively - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Poff, Adam)
June 29, 2018 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, Gregory K. Sobolski, Brenda L. Danek, Lauren K. Sharkey, and Lesley M. Hamming - filed by AbbVie Inc., Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy)
June 26, 2018 Filing 19 DECLARATION re #17 MOTION to Dismiss for Failure to State a Claim , #18 Opening Brief in Support (Sobolski) by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
June 26, 2018 Filing 18 OPENING BRIEF in Support re #17 MOTION to Dismiss for Failure to State a Claim filed by AbbVie Inc., Pharmacyclics LLC.Answering Brief/Response due date per Local Rules is 7/10/2018. (Tigan, Jeremy)
June 26, 2018 Filing 17 MOTION to Dismiss for Failure to State a Claim - filed by AbbVie Inc., Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy)
June 26, 2018 Filing 16 NOTICE of Appearance by Amy Michele Dudash on behalf of Acerta Pharma B.V. (Dudash, Amy)
June 26, 2018 Opinion or Order SO ORDERED, re #15 STIPULATION TO EXTEND TIME by which Defendants may respond to the Complaint to June 26, 2018 filed by Pharmacyclics LLC, AbbVie Inc., Set/Reset Answer Deadlines: AbbVie Inc. answer due 6/26/2018; Pharmacyclics LLC answer due 6/26/2018. By Judge Mary Pat Thynge on 6/26/2018. (fms)
June 25, 2018 Filing 15 STIPULATION TO EXTEND TIME by which Defendants may respond to the Complaint to June 26, 2018 - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
June 18, 2018 Opinion or Order SO ORDERED re (51 in 17-cv-1582-VAC-MPT, 14 in 18-cv-581-VAC-MPT) STIPULATION and Proposed Order to Extend Time. Signed by Judge Mary Pat Thynge on 6/18/18. Associated Cases: 1:18-cv-00581-VAC-MPT, 1:17-cv-01582-VAC-MPT(cak) Modified on 9/6/2018 (nms).
June 14, 2018 Filing 14 STIPULATION and Proposed Order to Extend Time - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms).
June 12, 2018 Filing 13 OPENING BRIEF in Support re #12 MOTION to Consolidate Cases filed by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..Answering Brief/Response due date per Local Rules is 6/26/2018. (Poff, Adam)
June 12, 2018 Filing 12 MOTION to Consolidate Cases - filed by Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Attachments: #1 Rule 7.1.1 Certification, #2 Text of Proposed Order, #3 Certificate of Service)Motions referred to Mary Pat Thynge.(Poff, Adam)
May 7, 2018 Opinion or Order SO ORDERED granting #11 Motion to Appear Pro Hac Vice of Dov P. Grossman to represent AstraZeneca UK Ltd. and AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 5/7/18. (cak)
May 4, 2018 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. Motions referred to Mary Pat Thynge.(Kraman, Pilar)
May 4, 2018 Filing 10 STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to June 25, 2018 - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy)
May 4, 2018 Opinion or Order SO ORDERED re #10 STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to June 25, 2018 filed by Pharmacyclics LLC, AbbVie Inc. Signed by Judge Mary Pat Thynge on 5/4/18. (cak)
May 2, 2018 Opinion or Order SO ORDERED granting #8 Motion to Appear Pro Hac Vice of Attorney David I. Berl, Stanley E. Fisher, Galina I. Fomenkova & Kevin D. Hoagland-Hanson - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. Signed by Judge Mary Pat Thynge on 5/2/18. (cak)
May 1, 2018 Filing 9 NOTICE of of Appearance of Teagan Gregory, Esquire on behalf of AstraZeneca UK Ltd. and AstraZeneca Pharmaceuticals LP by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Kraman, Pilar)
May 1, 2018 Filing 8 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Galina I. Fomenkova & Kevin D. Hoagland-Hanson - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. Motions referred to Mary Pat Thynge.(Kraman, Pilar)
April 25, 2018 CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb)
April 25, 2018 Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb)
April 25, 2018 ***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (cak)
April 20, 2018 Filing 7 Return of Service Executed by AstraZeneca UK Ltd., AstraZeneca Pharmaceuticals LP. AbbVie Inc. served on 4/20/2018, answer due 5/11/2018. (Poff, Adam)
April 20, 2018 Filing 6 Return of Service Executed by AstraZeneca UK Ltd., AstraZeneca Pharmaceuticals LP. Pharmacyclics LLC served on 4/20/2018, answer due 5/11/2018. (Poff, Adam)
April 19, 2018 Summons Issued with Magistrate Consent Notice attached as to AbbVie Inc. on 4/19/2018; Pharmacyclics LLC on 4/19/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)
April 18, 2018 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (ceg)
April 18, 2018 Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V. filed by Acerta Pharma B.V. (ceg)
April 18, 2018 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,459,554. (ceg)
April 18, 2018 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg)
April 18, 2018 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against AbbVie Inc., Pharmacyclics LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2364653.) - filed by AstraZeneca UK Ltd., Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(ceg)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Acerta Pharma B.V. et al v. Pharmacyclics LLC et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: AbbVie Inc.
Represented By: Jeremy A. Tigan
Represented By: Michael A. Morin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Pharmacyclics LLC
Represented By: Jeremy A. Tigan
Represented By: Michael A. Morin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: AstraZeneca Pharmaceuticals LP
Represented By: Adam Wyatt Poff
Represented By: Pilar Gabrielle Kraman
Represented By: James Kirkpatrick
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Acerta Pharma B.V.
Represented By: Adam Wyatt Poff
Represented By: Pilar Gabrielle Kraman
Represented By: John V. Gorman
Represented By: Olga Berson
Represented By: Amy Michele Dudash
Represented By: Robert Smyth
Represented By: Jody Barillare
Represented By: David W. Marston, Jr.
Represented By: Eric Kraeutler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: AstraZeneca UK Ltd.
Represented By: Adam Wyatt Poff
Represented By: Pilar Gabrielle Kraman
Represented By: James Kirkpatrick
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Intervenor defendant: Janssen Biotech, Inc.
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?